High Yield Handout: AKI Flashcards

1
Q

Define AKI clinically

A

Serum creatinine > 0.3 within 48 hours or >50% within 7 days

or

urine output <0.5 mL/kg/hour for >6 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

CardioRenal Syndrome

A

condition where therapy to relieve congestive symptoms of HF is limited by decline in renal function bidirectional

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do we calculate GFR

A

using creatinine a small frail, old person may have lower muscle mass therefore only experience a mild elevation of creatinine with renal insufficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

KDIGO stage 1

A

increase in serum creatinine >0.3 or 50-99%

or

urine output of <0.5 for 6-12 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

KDIGO stage 2

A

increase in serume creatinine of 100-199%

or

urine output of <0.5 for 12-24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

KDIGO stage 3

A

increase in serum creatinine >200%

increase in serum creatinine of >0.3 to >4.0

urine output of <0.3 for >24 hours or anuria >12 hours

initiation of renal replacement therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What data is important in the AKI case we had

A

increase in BUN/Cr

BNP declining

improvement of chest x-ray

normal EF per echo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

AKI symptoms

A

oliguria

dyspnea

worsening edema

tachycardia

hypotension

JVD

liver distension/tenderness

distended abdomen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

anascara

A

Is severe generalized edema that extends from the lower extremity proximally. It can
cause ascites as well as subcutaneous edema; associated with heart failure, cirrhosis, severe
malnutrition and renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Fluid wave

A
detects large volumes of free intrabdominal fluid. It has a specificity of 80-90%; a
positive finding rules in ascites. However, its sensitivity is ~50%, so a negative test does not
exclude ascites (i.e. it is volume dependent).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PND

A

Describes episodes of sudden dyspnea and orthopnea that awaken patient from sleep prompting the patient to sit up and stand up. There may be associated wheezing and coughing. PND may be mimicked by nocturnal asthma attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

puddle sign

A

~40-~50% sensitivity especially with small amount of ascites.

The patient places the ulnar surface of their
hand along the abdominal vertical midline. The
operator places one hand on one flank and taps
gently on the opposite flank. A positive sign
when the operator feels a moderate to strong
fluid wave emanating into the contralateral
side.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

OSE for kidney

A

T10-T11

vagus nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Upper Ureter

A

T10-T11

Vagus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Lower Ureter

A

T12-L2

pelvic splanchnic nerve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bladder

A

T12-L2

pelvic splanchnic nerve

17
Q

Kidney Chapman points

A

Anterior: one inch lateral and one inch
superior to the umbilicus

Posterior: between the transverse process
of T12 and L1 (on the ipsilateral side)

18
Q

5 model approach: Biomechanical

A

SD of OA/AA
SD of T-spin (T10-T11)
SD of psoas

19
Q

5 model approach:

Respiratory/Circulatory

A

O2 via mask/nasal canula

Lymphatics

diaphragms

Thoracic Area (pec traction/doming the diaphragm/thoracic pump)

Abdominal Area (abdominal pump/sacral rocking/pelvic diaphragm)

Extremity (effleurage/petrissage/pedal pump)

Rib raising

20
Q

5 model approach:

Neurologic

A

see other cards regarding nerve levels

21
Q

5 model approach:

Metabolic/Energetic/Immune

A

Loop diuretics

Fluid restriction

Remove offending agents like NSAIDs, PPI

Adjust meds based on renal function

Monitor I/O’s, weights

22
Q

5 model approach:

Behavioural

A

Exercise

Diet – restrict fluids

Avoid offending agents

Better management of CHF (inciting cause)

23
Q

What are the possible mechanisms to account for AKI in conjunction with
AHF?

A

neurohumoral adaptations

reduced renal perfusion

increased renal venous pressure

associations with heart failure with preserved ejection fraction

24
Q

neurohumoral adaptations and reduced renal perfusion

A

in the setting of HF, hemodynamic
derangements trigger activation of the sympathetic nervous system and
RAAS and increases in the release of vasopressin (andidiuretic hormone)
and endothelin-1, which promote salt and water retention and systemic
vasoconstriction. These pathways lead to disproportionate reabsorption
of urea compared with that of creatinine. They also overwhelm the
vasodilatory and natriuretic effects of natriuretic peptides, nitric oxide,
prostaglandins, and bradykinin. The systemic vasoconstriction increases
cardiac afterload which reduces cardiac output, can further reduce renal
perfusion.

25
Q

increased renal venous pressure

A

Increases in intra-abdominal or central
venous pressure, which should increase renal venous pressure, reduces
GFR. In other words, there is an inverse relationship between central
venous pressure and GFR. However, the mechanism by which renal
venous pressure might lead to reduction in GFR is not well understood

26
Q

Associations with heart failure with preserved ejection fraction (HFpEF):

A

renal dysfunction can lead to metabolic derangements resulting in
systemic inflammation and microvascular dysfunction, which can cause
cardiomyocyte stiffening, hypertrophy and interstitial fibrosis. Exact
relationships are not well understood.

27
Q

how do we treat AKI

A
  1. Remove offending agents: NSAIDS, PPI, etc.
  2. Judicious use of loop diuretics (furosemide)
  3. Adjust medication dosing based on renal function
  4. Supportive care: oxygen
  5. Monitor weight, I’s & O’s
  6. Fluid restriction
  7. Monitor electrolytes (Na+, K+ ,Ca+, Mg+, etc.)
  8. Case management/manager
  9. Dietary consult
28
Q

long term management for AKI

A
  1. Discussion with patient regarding personal wishes regarding Dialysis
    (both short and long-term), as well as other end-of-life matters such as
    Living Will and DPAHC.
  2. Avoid nephrotoxic drugs, including OTC preparations such as NSAIDs,
    PPI, etc.
  3. Regular monitoring of electrolytes, patient weight, fluid status, etc.
29
Q

complications of long term AKI management

A
  1. Progression to oligouria or anuria: Dialysis (Renal Replacement Therapy) may be ‘initiated
    emergently when life-threatening changes in fluid, electrolyte, and acid-base balance exist,’ per
    the KDIGO guidelines. RRT should be continued until renal function is recovered or because
    continued provision of renal support is no longer consistent with the overall goals of care for
    the patient.